DM

Deepthi Mai Eeranki

Active Director Director DIN 11466299
DIN 11466299 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepthi Mai Eeranki

Data last updated:

Deepthi Mai Eeranki is a Director at Credas Pharmacy Private Limited (since 2025). The company operates in Pharma.

DIN 11466299
Primary Designation Director
Industry Pharma
First Appointment 20 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Credas Pharmacy Private Limited U21000TS2024PTC182444
Director20 Dec 2025Active

Board colleagues of Deepthi Mai Eeranki

NameDINCompanyDesignation
Adithya Donikena10734922Credas Pharmacy Private LimitedIndividual Subscriber
Donikena Sahithya10517107Credas Pharmacy Private LimitedDirector

Directorship timeline

Open interactive timeline →
Credas Pharmacy Private Limited
Premium access

Shareholding and investment profile for Deepthi Mai Eeranki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepthi Mai Eeranki

Deepthi Mai Eeranki currently holds 1 directorship: Credas Pharmacy Private Limited (Director, since 20 Dec 2025).

Deepthi Mai Eeranki was first appointed on 20 Dec 2025 as Director at Credas Pharmacy Private Limited.

The current boards of Deepthi Mai Eeranki's companies include Adithya Donikena (Credas Pharmacy Private Limited), Donikena Sahithya (Credas Pharmacy Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available